Methylene Blue is a blue dye used in medicine. It's sometimes used to help treat poisoning from cyanide. It can also be used to check if someone has swallowed something harmful.
Every report comes from a Lived member, sent anonymously.
Have you tried Methylene Blue for Methemoglobinemia?
Methylene blue is a deep blue dye that is also a medicine. As an injection, sold under the brand name ProvayBlue and as generic methylene blue injection, it is approved by the US Food and Drug Administration (FDA) to treat acquired methemoglobinemia in children and adults. In methemoglobinemia, some of the hemoglobin in red blood cells (the protein that carries oxygen) changes into a form called methemoglobin, which holds on to oxygen instead of releasing it to the body's tissues. The acquired form is usually triggered by a medicine or chemical, such as the numbing medicine benzocaine, the antibiotic dapsone or nitrites. It can cause bluish skin, headache, fatigue, shortness of breath and confusion, and severe cases can be life threatening. Hospital teams also use methylene blue outside its approved use. Surgeons use it as a dye to make certain tissues and fluids easier to see, and intensive care teams sometimes give it as a rescue treatment for dangerously low blood pressure in septic shock when standard medicines are not enough. A small amount of methylene blue is also one ingredient in some prescription combination tablets for painful or urgent urination, such as Uribel. Methylene blue is now widely promoted on social media and sold online as a supplement for memory, energy or longevity. There is no good clinical evidence that it improves memory, energy or longevity. Early hopes that it might treat Alzheimer's disease have not been met, and supplement products carry the same serious drug interaction risk as the medicine.
Inside red blood cells, methylene blue is converted by an enzyme into a related compound called leucomethylene blue. That compound turns methemoglobin back into normal hemoglobin, which can again release oxygen to the tissues. This is why methylene blue can reverse methemoglobinemia quickly, often within hours. The conversion step depends on a red blood cell enzyme pathway that people with G6PD (glucose-6-phosphate dehydrogenase) deficiency, an inherited condition affecting red blood cells, cannot run properly. In them, methylene blue may not work and can instead damage red blood cells. Methylene blue also blocks monoamine oxidase, an enzyme that breaks down serotonin and related brain chemicals. This effect is not part of how it treats methemoglobinemia, but it explains its most serious interaction with antidepressants and other medicines that raise serotonin. In septic shock, it is thought to raise blood pressure by blocking the nitric oxide signaling that makes blood vessels relax.
For methemoglobinemia, methylene blue is given in a hospital or emergency department as a slow injection into a vein over 5 to 30 minutes. The dose is based on body weight. If the methemoglobin level stays high or symptoms continue, one repeat dose may be given an hour later. People with moderate or severe kidney disease usually receive only a single dose. If two doses do not work, the care team turns to other treatments rather than giving more. Oral combination tablets for urinary symptoms are taken by mouth as prescribed and contain only a small amount of methylene blue. Supplement products sold online have no approved dose, and their strength and purity are not checked the way a medicine's are.
Methylene blue turns urine blue or blue-green, and it can also tint stool and skin. This is expected and fades as the dye leaves the body. In studies of the injection, the most common side effects were headache, nausea, diarrhea, low potassium or magnesium levels, and muscle jerks. Some people feel dizzy or confused or have blurred vision for a while afterward, so driving and operating machinery should wait until these effects have passed. The skin can also become more sensitive to light, so protection from strong light is sensible after treatment. Methylene blue can break down red blood cells, causing anemia that may not appear until a day or more after treatment, sometimes severe enough to need a transfusion. The care team may check blood counts in the days afterward, and unusual tiredness, shortness of breath, dark urine or yellowing of the skin or eyes in that period is a reason to call them. Severe allergic reactions, including anaphylaxis, have been reported and are treated immediately by the team giving the infusion.
Methylene blue carries an FDA boxed warning, the agency's most prominent warning, about serotonin syndrome, which can be serious or fatal. The risk is highest when it is combined with medicines that raise serotonin, including selective serotonin reuptake inhibitor (SSRI) and serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressants (such as sertraline and venlafaxine), MAOIs (an older class of antidepressants), and opioid pain medicines. The label also names other antidepressants (bupropion, also sold as Wellbutrin, plus clomipramine and mirtazapine), the anti-anxiety medicine buspirone, the antibiotic linezolid and the cough suppressant dextromethorphan. In an emergency the team may still decide methylene blue is necessary, and will then use the lowest dose and watch closely. Medicines that raise serotonin are then avoided for 72 hours after the last dose, and the care team will say when a regular antidepressant can be restarted. This interaction applies to supplement products too, which is a key reason not to take methylene blue on your own while using any of these medicines. Serotonin syndrome can cause agitation, confusion or hallucinations, a fast heartbeat, fever and heavy sweating, muscle twitching, stiffness or tremor, and seizures. Anyone who develops these symptoms after methylene blue needs immediate medical attention. Methylene blue should not be given to people with G6PD deficiency, because it can cause severe destruction of red blood cells, or to people who have had a severe allergic reaction to it or a similar dye. It may harm a developing baby, so in pregnancy it is used only when the benefit outweighs that risk. Breastfeeding should be paused during treatment and for up to 8 days afterward.
When methylene blue is used for methemoglobinemia, people often feel better and look less blue within hours, and the team repeats blood tests to confirm the methemoglobin level has fallen. Finding and avoiding the medicine or chemical that caused the problem is a central part of care, because the condition can come back. With some triggers, such as dapsone, levels can rebound after the first response, and other treatments may be needed. While methylene blue is in the bloodstream, finger-clip pulse oximeters can show falsely low oxygen readings, so the team may rely on blood samples instead. The blue color of urine and skin is temporary. Most people need only one or two doses, so treatment is short, but the warning period for serotonin-raising medicines and the possibility of delayed red blood cell breakdown extend a few days beyond the infusion.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Methylene Blue, what you've noticed, or ask the community a question.